麗年國際(09918.HK)2023年歸母淨利120萬港元 同比減少92%
格隆匯3月26日丨 麗年國際(09918.HK)公吿,集團於2023財政年度錄得收益12.27億港元,同比減少或8.1%。有關減少乃主要由於2023年來自幾名主要客户的客户訂單減少。2023財政年度公司權益持有人應占年內溢利為120萬港元,同比減少92%。每股基本及攤薄盈利1.2港仙。
得益於公司對業務發展及工程的持續不懈投入,2024年研發管線已較去年大為豐富。COVID-19疫情結束後,凜冬驟降。全球經濟形勢崎嶇暗淡。這可能是充滿疑慮的時代,亦可能是充滿光明的時節。但公司以蓬勃活力、睿智才華、團隊合作共創輝煌,定能將絕望冬轉化為希望之春。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.